You are here

chronic immune thrombocytopenic purpura

Glaxo's Promacta Holds Promise

Yahoo/Zacks.com

Tue, 06/17/14 - 06:50 pm

chronic immune thrombocytopenic purpura

FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder

Yahoo/PR NewsWire

Sat, 02/26/11 - 10:12 am

chronic immune thrombocytopenic purpura

Glaxo’s Revolade Fails to Win Recommendation of U.K. Agency

Bloomberg

Thu, 06/10/10 - 09:27 am

chronic immune thrombocytopenic purpura